Does SINTILIMAB Cause Immune-mediated myocarditis? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Immune-mediated myocarditis have been filed in association with SINTILIMAB. This represents 2.9% of all adverse event reports for SINTILIMAB.
19
Reports of Immune-mediated myocarditis with SINTILIMAB
2.9%
of all SINTILIMAB reports
5
Deaths
8
Hospitalizations
How Dangerous Is Immune-mediated myocarditis From SINTILIMAB?
Of the 19 reports, 5 (26.3%) resulted in death, 8 (42.1%) required hospitalization, and 2 (10.5%) were considered life-threatening.
Is Immune-mediated myocarditis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SINTILIMAB. However, 19 reports have been filed with the FAERS database.
What Other Side Effects Does SINTILIMAB Cause?
Myelosuppression (127)
Nausea (77)
Rash (72)
Vomiting (68)
Off label use (64)
Hypothyroidism (62)
Diarrhoea (61)
Fatigue (60)
Anaemia (59)
Pyrexia (51)
What Other Drugs Cause Immune-mediated myocarditis?
PEMBROLIZUMAB (599)
NIVOLUMAB (444)
IPILIMUMAB (248)
CARBOPLATIN (93)
DURVALUMAB (74)
LENVATINIB (66)
DOXORUBICIN (59)
PACLITAXEL (58)
PEMETREXED (43)
ATEZOLIZUMAB (37)
Which SINTILIMAB Alternatives Have Lower Immune-mediated myocarditis Risk?
SINTILIMAB vs SIPONIMOD
SINTILIMAB vs SIPULEUCEL-T
SINTILIMAB vs SIROLIMUS
SINTILIMAB vs SIRUKUMAB
SINTILIMAB vs SITAGLIPTIN